All News

Do women unfairly pay more for prescriptions? According to Senators Olympia Snow (R-ME) and Harry Reid (D-NV), who introduced the Equity in Prescription Insurance and Contraceptive Coverage Act, they do.

BELSE, Swizterland - Roche Holding Ltd., Switzerland, announced plans to acquire Corange Ltd., the Bermuda-based holding company of the Boehringer Mannheim Group, Amsterdam.

Advertising campaigns for prescription drugs are influencing doctor-patient relationships, according to a new marketing study.

DUBLIN, Ireland - Elan Corp. announced plans to add 50 new reps to its sales force in order to market its anticipated line of antiepilepsy products. The group will target neurologists and other physicians who specialize in the treatment of epilepsy.

Solvay Pharmaceuticals, Pharmacia & Upjohn Inc. and the Obsessive Compulsive Foundation have launched a new public awareness campaign to help children and adults recognize and treat obsessive-compulsive disorder.

A team of psychiatrists has developed new practical guidelines for treating patients suffering from obsessive-compulsive disorder.

Timely development of new products and the recruiting and retaining of talented people are the top two strategic issues facing the pharmaceutical, biotechnology and medical device industry, according to an annual survey conducted by Coopers & Lybrand.

Prices for prescription drugs rose 2.3% in the first quarter of 1997, according to the research firm IMS America, Plymouth Meeting, PA.

The Office of the U.S. Trade Representatives released its annual report on the adequacy and effectiveness of intellectual-property protection in countries trading with the United States.

McNeil Consumer Products Company, the makers of Tylenol,® launched a national immunization education program for health care providers and parents during National Infant Immunization Week, April 20-26.

Biogen Inc., Cambridge, MA, introduced a new support program to help patients, their care partners and health care professionals manage multiple sclerosis.

Find your stage personality.

Learning and training from home is just around the corner.

This article, the second in a series of three, covers the integration of multimedia computers and interactive software into sales training programs.

What disease management offers to patients and reps.

Avoid these mistakes to make the best deal.

In conjunction with the FDA, PhRMA and BIO are developing FDA legislative reform recommendations for Congress to consider.

Rep profile

The United States pharmaceutical industry experienced an unprecedented real growth rate of more than 10% in 1996, according to IMS, a Plymouth Meeting, PA-based unit of Cognizant Corp.

Medical Economics, Northfield, IL, welcomed Kristen Mally as the new editor of Pharmaceutical Representative in April. She replaced Laura Ramos, who headed the publication from 1993 to 1997.

Searle, Skokie, IL, has developed an interactive corporate Web site. The site includes The Pipeline Game allows players to develop a new drug and take it all the way through market clearance.

Group purchasing organizations grew in numbers, consolidated and expanded services last year, according to SMG, a Chicago-based market research and consulting firm.

WASHINGTON - The FDA proposed a new use initiative to speed up the development of new and supplemental uses of medications.

Pharmaceutical price regulations largely fail to control drug spending and adversely affect incentives for pharmaceutical research and development, according to a book from the American Enterprise Institute, Washington.

The Academy of Managed Care Pharmacy, Alexandria, VA, released a revised position statement supporting the appropriate design and use of drug formularies.

Before a customer's need can be satisfied, there are various layers of selling activity that take place.

This article is the first of a three-part series on reps and technology.

Finding your way around the World Wide Web.

Due to an increasing number of extraordinary partnerships and innovative disease management programs among certain managed care and pharmaceutical firms, the face of disease management is finally changing, even if only slightly.

Practice Paterns Science Inc., St. Louis, has developed PTE-Registry,™ a national comparative database designed to help pharmaceutical and biotechnology companies identify the drugs that produce more efficient treatment patterns with fewer side effects